Recursion Pharmaceuticals is using robots to find treatments for rare diseases like sickle cell anemia and cystic fibrosis. » Read More
By: Bryan Borzykowski, special to CNBC.com
Obamacare repeal and failed insurance mergers have been dominating health-care headlines, but some surprise stock winners may emerge. » Read More
By: Chris Morris
Hyundai debuts an exoskeleton device at CES that plans to help paraplegics and the elderly improve mobility. » Read More
Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid.
Innovation has always been the blood pumping through the body of the pharma industry, but in recent years the supply seemed to be getting poorer.
The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because its vulnerable to hacking.
Ebola briefly returned to the headlines this week with a scare at a hospital in New York, but the deadly virus continues to claim victims in West Africa.
A man bitten by a rattlesnake this month says he received a $153,000 hospital bill.
As sports grapples with the effects of injuries, one area of medicine is looking to make pain and recovery a thing of the past.
Hospitals are taking on Yelp with their own ratings and review system.
GE Vice Chairman John Rice says public private partnerships can help provide solutions to today's toughest health-care challenges.
An Australian spent four days in hospital after her skinny jeans caused her to collapse, NBC News reports.
Nearly 75 percent percent of Humana’s revenue comes from Medicare, more than the other big insurers. Here's why Humana is such a hot commodity.
Consolidation in the health insurance industry is "potentially dangerous" for the hospital business, Mount Sinai Health System's CEO said Thursday.
There have only been four flu pandemics since the start of the 20th century, yet concerns are widening about the potential for a new outbreak.
As the government program reaches the half-century mark, it needs to get into the digital age, says this University of Rochester professor.
This company is setting itself apart from other health insurers by emphasizing technology, data and its easy-to-understand services.
Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests.
The robots are pricy, but this hospital hopes to save labor costs.
A new report reveals that official estimates for the nation's future health spending are nearly 11 percent less that previously projected.
On Oct. 1, all U.S. medical and billing codes will migrate to a new global standard, but is the health-care system ready for the change?
Ventas said it would buy privately held hospital chain Ardent Medical Services for $1.75 billion in cash.
How many of you who have Obamacare went to the doctor's office more often?
Get the best of CNBC in your inbox